WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug
ChinaSourcingNews.com
Product Quality, Supply Chain, Outsourcing, Manufacturers, Suppliers, Import/Export and Trading In China